Clinical Trial Update: Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating mesenchymal stem cells to heal articular cartilage defects; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Defect of Articular Cartilage | Phase 1 | Status: UNKNOWN